Journal of the Neurological Sciences

Papers
(The H4-Index of Journal of the Neurological Sciences is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis446
Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom187
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review171
A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications144
Cerebrospinal fluid in COVID-19: A systematic review of the literature133
Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms125
Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease108
Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community98
Anosmia is associated with lower in-hospital mortality in COVID-1976
Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment68
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series66
COVID-19 in multiple sclerosis patients and risk factors for severe infection66
Neurological involvement associated with COVID-19 infection in children65
Neurology of COVID-19 in Singapore64
Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series63
Wernicke-Korsakoff syndrome despite no alcohol abuse: A summary of systematic reports58
Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-1955
Mediterranean diet adherence, gut microbiota, and Alzheimer's or Parkinson's disease risk: A systematic review52
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose51
Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm43
Brucellosis39
Exosomal TAR DNA-binding protein-43 and neurofilaments in plasma of amyotrophic lateral sclerosis patients: A longitudinal follow-up study38
New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic?38
The pathophysiology of Parkinson's disease tremor38
Neurologic and cognitive sequelae after SARS-CoV2 infection: Different impairment for ICU patients36
Consensus on the treatment of dysphagia in Parkinson's disease34
Neuromyelitis optica spectrum disorders34
Parkinson's disease after COVID-1933
Commercially available seizure detection devices: A systematic review32
Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?31
IgG regulation through FcRn blocking: A novel mechanism for the treatment of myasthenia gravis31
0.13865804672241